Life Sciences Global Cities Comparison Report 2024
Sector insightsComparing how London and other global cities perform across investment, talent, infrastructure and innovation.
Overview
The Global Cities Comparison Report analyses how London compares with global peers including Boston, San Francisco, Singapore and Amsterdam. It reviews metrics such as research output, investment levels, infrastructure readiness and talent pipeline quality. The findings show that London combines scientific excellence, policy stability and a mature financial ecosystem that continues to attract international companies. The report also highlights opportunities to build further resilience by supporting advanced manufacturing capacity and cross-sector collaboration. Overall, London remains one of the most balanced global ecosystems for life sciences growth.
Key takeaways
- Global leader in academic and clinical excellenceLondon’s concentration of research universities, teaching hospitals and institutes positions it among the top global cities for translational science and discovery.
- Strong investment and innovation ecosystemA deep capital market and growing venture ecosystem underpin London’s competitiveness, attracting both early-stage and growth investment from international funds.
- Opportunities to strengthen manufacturing and scale-upThe report identifies scope to expand advanced manufacturing capacity and improve infrastructure for scaling firms, supporting long-term global competitiveness.
